LamivudineBenzoxazinesOxazinesReverse Transcriptase InhibitorsAnti-HIV AgentsHepatitis B, ChronicOrganophosphonatesNevirapineAdenineDrug Resistance, ViralHIV InfectionsHepatitis B virusZidovudineAntiviral AgentsDideoxynucleosidesStavudineHepatitis B e AntigensOxidoreductases, N-DemethylatingDrug Therapy, CombinationViral LoadDidanosineHIV-1RitonavirIndinavirPyrimidinonesHepatitis BNelfinavirLopinavirAntiretroviral Therapy, Highly ActiveHIV Protease InhibitorsHIV Reverse TranscriptaseCD4 Lymphocyte CountDNA, ViralAlanine TransaminaseAryl Hydrocarbon HydroxylasesDrug InteractionsTreatment OutcomeTreatment FailureHepatitis B Surface AntigensAntibiotics, AntitubercularAnti-Retroviral AgentsRNA, ViralDrug Resistance, Multiple, ViralPlasmaNucleosidesMutationRifampinSleep Arousal DisordersArea Under CurveHIVDrug Administration ScheduleHepatitis B AntibodiesGene Products, polZalcitabineGuanineDrug CombinationsGenotypeLiver TransplantationDrug MonitoringInterferon-alphaDideoxynucleotidesLiver CirrhosisDouble-Blind MethodDyssomniasLipodystrophyRecurrenceDeoxycytidineHepatitis B Core AntigensProspective StudiesVirus ActivationCytidine TriphosphateBotswanaAcquired Immunodeficiency SyndromeArabinofuranosyluracilImmunoglobulinsDrugs, GenericDelavirdineInfectious Disease Transmission, VerticalRNA-Directed DNA PolymeraseDrug Resistance, Microbial2-AminopurineVirus ReplicationPregnancy Complications, InfectiousChromatography, High Pressure LiquidTime FactorsTherapeutic EquivalencyPharmacogeneticsCote d'IvoireRetrospective StudiesCytochrome P-450 CYP3ADiarylquinolines